Indikationen für implantierbare Loop-Rekorder bei Kanalopathien und ventrikulären Tachykardien

Ritter MA, Kochhauser S, Duning T et al (2013) Occult atrial fibrillation in cryptogenic stroke: detection by 7‑day electrocardiogram versus implantable cardiac monitors. Stroke 44:1449–1452 Solano A, Menozzi C, Maggi R et al (2004) Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. Eur Heart J 25:1116–1119 Moya A, Sutton R, Ammirati F et al (2009) Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30:2631–2671 Priori SG, Blomstrom-Lundqvist C, Mazzanti A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36:2793–2867 Priori SG, Wilde AA, Horie M et al (2013) Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 10:1389–1406 Volosin K, Stadler RW, Wyszynski R et al (2013) Tachycardia detection performance of implantable loop recorders: results from a large „real-life“ patient cohort and patients with induced ventricular arrhythmias. Europace 15:1215–1222 Avari Silva JN, Bromberg BI, Emge FK et al (2016) Implantable loop recorder monitoring for refining management of children with inherited arrhythmia syndromes. J Am Heart Assoc. doi:10.1161/JAHA.116.003632 Goldenberg I, Horr S, Moss AJ et al (2011) Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol 57:51–59 Probst V, Veltmann C, Eckardt L et al (2010) Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation 121:635–643 Eckardt L, Probst V, Smits JP et al (2005) Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 111:257–263 Kubala M, Aissou L, Traulle S et al (2012) Use of implantable loop recorders in patients with Brugada syndrome and suspected risk of ventricular arrhythmia. Europace 14:898–902 Eckardt L, Wasmer K, Kobe J et al (2013) Early repolarisation. A dilemma of risk stratification. Herzschrittmacherther Elektrophysiol 24:115–122 Gatzoulis KA, Tsiachris D, Arsenos P et al (2014) Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function. Int J Cardiol 176:1449–1451 Pokorney SD, Friedman DJ, Calkins H et al (2016) Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials. Heart Rhythm. doi:10.1016/j.hrthm.2016.04.001 Bloch Thomsen PE, Jons C, Raatikainen MJ et al (2010) Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation 122:1258–1264 Katritsis DG, Siontis GC, Camm AJ (2013) Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias. Prog Cardiovasc Dis 56:133–142 Goldberger JJ, Subacius H, Patel T, Cunnane R, Kadish AH et al (2014) Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 63:1879–1889 Basso C, Perazzolo Marra M, Rizzo S et al (2015) Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation 132:556–566 Elliott PM, Anastasakis A et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733–2779 O’Mahony C, Jichi F, Pavlou M et al (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 35:2010–2020 Balt JC, Wijffels MC, Boersma LV et al (2014) Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy. Heart 100:1865–1870 Veselka J, Jensen MK, Liebregts M et al (2016) Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. Eur Heart J 37:1517–1523 Kenny D, Chakrabarti S, Ranasinghe A et al (2009) Single-centre use of implantable loop recorders in patients with congenital heart disease. Europace 11:303–307 Sayed RH, Rogers D, Khan F et al (2015) A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis. Eur Heart J 36:1098–1105 Weidemann F, Maier SK, Stork S et al (2016) Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced Fabry cardiomyopathy. Am J Cardiol 118:264–274 Finsterer J, Stollberger C, Keller H (2012) Arrhythmia-related workup in hereditary myopathies. J Electrocardiol 45:376–384